They’ve expanded from treating erectile dysfunction and hair loss to offering weight ... as they charge a separate membership fee aside from the cost of the medication. 5. Hims and Hers Hims and Hers ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Hims & Hers (NASDAQ: HIMS) stock has done well since the company went public a few years ago. It has soared by over 193% in ...